Spotlight June 2021: Endotoxin – the reason for false-positive toxicity testing for advanced materials? 

Home > Spotlight June 2021: Endotoxin – the reason for false-positive toxicity testing for advanced materials? 

Advanced materials, but also nanomaterials are closely examined to determine whether they trigger biological effects that could be harmful to humans and the environment before they are used in products. This also includes such materials as titanium dioxide, which has been used in a wide variety of products for more than 50 years. A particularly important biological reaction to “foreign substances” in humans and animals is the inflammatory response, as this represents a defence mechanism in which the body defends itself with various reactions: redness, heating (fever), swelling and pain are the first signs and possibly lead to a functional impairment of the organ that is affected. As a result, this reaction is also particularly frequently studied in toxicology laboratories and almost as frequently misinterpreted.

But what are the reasons for the frequently false-positive results, e. g. with gold particles or the titanium dioxide particles mentioned above? It has long been known that a bacterial cell component is responsible for such false determinations. This is because the so-called “endotoxin” or lipopolysaccharide (LPS) is found everywhere in our environment, even without bacteria, and particularly likes to bind to small particles, such as nanoparticles [1, 2]. This endotoxin then triggers the defence reaction without the material itself having to contribute anything.

In their recent review article, the Italian/Spanish group draws attention to the fact that before measuring an inflammation-inducing effect of materials, it is essential to examine the material to determine whether it contains bacterial contaminants (endotoxin) [Mangini et al., 2021]. And in addition, they indicate that the selection of the appropriate determination method is also important, since the nanoparticles can interact with the test methods, causing additional errors that can lead to false-positive or even false-negative evaluation of the results. However, from a regulatory point of view there is no rule (except for medical applications) that requires the detection or absence of endotoxins when it comes to the toxicological evaluation of advanced materials. Thus, it can be assumed that many of these materials are contaminated with endotoxin and therefore the statements about their inflammatory capacity may be incorrect. The authors therefore present a decision tree that should be applied before any testing of nanomaterials or advanced materials to avoid exactly these mistakes. On the one hand, the question of whether endotoxin is present in the samples must be answered, and on the other hand, it must also be considered whether the appropriate test has been selected that should be used for the material in question.

The DaNa project also evaluates the literature on toxicity according to this criterion, among others, and has included the detection of endotoxin into the catalogue of evaluation points (see also https://nanopartikel.info/en/knowledge/literature-criteria-checklist/).

 

Original Publication:

Mangini, M et al. (2021). Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding. Nanotoxicology, 15(4): 558-576.

 

Further literature cited

  1. Bianchi, MG et al. (2017). Lipopolysaccharide Adsorbed to the Bio-Corona of TiO2 Nanoparticles Powerfully Activates Selected Pro-inflammatory Transduction Pathways. Front Immunol, 8 866.
  2. Li, Y et al. (2017). Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation. Nanotoxicology, 11(9-10): 1157-1175.
Spotlight June 2021: Endotoxin – the reason for false-positive toxicity testing for advanced materials? 

Weitere Spotlights


Spotlight February 2022: Probabilistic risk assessment – the keystone for the future of toxicology

Spotlight February 2022: Probabilistic risk assessment – the keystone for the future of toxicology

The basics of toxicology are constantly being reconsidered, and the approach to risk assessment is therefore constantly being put to the test, because, as William Osler is cited in this publication, “Medicine (toxicology) is a science of uncertainty and an art of probability“. In this recent paper, the team around Thomas Hartung (Johns-Hopkins University/University of […]

Read more

Spotlight December 2021: Silica nanoparticles improve plant disease resistance

Spotlight December 2021: Silica nanoparticles improve plant disease resistance

The resistance of plants to various pathogens is often increased in agriculture with various chemicals (“fertilizers”). A new direction is being taken with the use of nanoparticles. These can be sprayed on the plants. In the present study, the model plant Arabidopsis was used to investigate whether silicon dioxide nanoparticles (SiO2) can increase resistance to […]

Read more

Spotlight December 2020: Rethinking Nanosafety – Part II

Spotlight December 2020: Rethinking Nanosafety – Part II

In December we would like to draw attention to the special issue: Rethinking Nanosafety – Part II in small. In the July Spotlight we already presented Part I. This special issue “Rethinking Nanosafety – Part II” also features research papers by renowned scientists in the field of nanosafety research. The first part of this special […]

Read more

Spotlight August 2021: Towards FAIR nanosafety data

Spotlight August 2021: Towards FAIR nanosafety data

In August we would like to present a paper on FAIR data. The paper published in Nature Nanotechnology in June 2021 summarises the challenges and provides recommendations for the efficient reuse of nanosafety data in line with the recently established FAIR guiding principles: findable, accessible, interoperable and reusable. This article summarises the know-how on the […]

Read more

Skip to content